| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Allograft rejection 3 genes, 3 drugs (DrugBank), 27 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 2 | Antifolate resistance 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 3 | Asthma 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 4 | Autoimmune thyroid disease 3 genes, 3 drugs (DrugBank), 27 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 5 | Cell adhesion molecules (CAMs) 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 6 | cGMP-PKG signaling pathway 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] OPRD1 |
D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 7 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] C5AR1 |
D11093 |
Avacopan |
[4] 43, 44, 222, 223 |
| 8 | Cytokine-cytokine receptor interaction 3 genes, 4 drugs (DrugBank), 11 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] IL5RA |
D09874 |
Benralizumab |
[2] 44, 45 |
| [1] TNFSF13B |
D03068 |
Belimumab |
[8] 11, 43, 44, 46, 49, 51, 53, 222 |
| 9 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] OPRM1 |
D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 10 | Fc epsilon RI signaling pathway 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 11 | Folate biosynthesis 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 12 | Graft-versus-host disease 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 13 | Hematopoietic cell lineage 3 genes, 4 drugs (DrugBank), 43 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] IL5RA |
D09874 |
Benralizumab |
[2] 44, 45 |
| [1] MS4A1 |
D02994 |
Rituximab |
[42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| 14 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 15 | Inflammatory bowel disease (IBD) 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 16 | Intestinal immune network for IgA production 4 genes, 4 drugs (DrugBank), 28 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNFSF13B |
D03068 |
Belimumab |
[8] 11, 43, 44, 46, 49, 51, 53, 222 |
| 17 | JAK-STAT signaling pathway 2 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] IL5RA |
D09874 |
Benralizumab |
[2] 44, 45 |
| 18 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 1 drug (DrugBank), 24 diseases shown |
[1] CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 19 | Metabolic pathways 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 20 | Morphine addiction 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] OPRM1 |
D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 21 | Neuroactive ligand-receptor interaction 5 genes, 5 drugs (DrugBank), 60 diseases shown |
[1] C5AR1 |
D11093 |
Avacopan |
[4] 43, 44, 222, 223 |
| [1] NR3C1 |
D00472 |
Prednisolone |
[38] 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 |
| D00981 |
| D00982 |
| D01239 |
| D01998 |
| D02156 |
| D03301 |
| D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| D00385 |
Triamcinolone |
[18] 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
| D00983 |
| D00984 |
| D00985 |
| D06216 |
| [3] OPRD1, OPRK1, OPRM1 |
D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 22 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] TNFSF13B |
D03068 |
Belimumab |
[8] 11, 43, 44, 46, 49, 51, 53, 222 |
| 23 | One carbon pool by folate 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 24 | Pathways in cancer 2 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] IL5RA |
D09874 |
Benralizumab |
[2] 44, 45 |
| 25 | Rheumatoid arthritis 3 genes, 2 drugs (DrugBank), 25 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNFSF13B |
D03068 |
Belimumab |
[8] 11, 43, 44, 46, 49, 51, 53, 222 |
| 26 | Sphingolipid signaling pathway 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] OPRD1 |
D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 27 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] C5AR1 |
D11093 |
Avacopan |
[4] 43, 44, 222, 223 |
| 28 | Systemic lupus erythematosus 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 29 | T cell receptor signaling pathway 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 30 | Th1 and Th2 cell differentiation 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 31 | Toll-like receptor signaling pathway 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 32 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 24 diseases shown |
[1] CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 33 | Type I diabetes mellitus 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 34 | Viral myocarditis 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |